Advanced Bronchogenic Carcinoma with Secondary Liver Metastasis and Sepsis as an Initial Hospital Presentation; The Shortcomings of Preventive Care Medicine in Nigeria

Evbayekha O. Endurance MD.1*, Izirein O. Hannah MD.2, Ohikhuai E. Evidence B. Pharm, MPH.3, Alugba Gabriel MD.4, Okelue E. Okobi MD MSC.5, Okorare Ovie MD.6, Ofumwengbe-Evba Osaruyi MD.7

Abstract

Chronic diseases are the most prevalent worldwide. Evidence-based medicine points to primary care as the most effective tool to minimize the burden through primary prevention and early detection of diseases. In keeping with this, the primary care arm of medicine can be regarded as the gatekeeper of public health. The rising incidence of chronic diseases indicates that the primary care system may fail to live up to its responsibility. We present a case of an elderly male who came to the hospital with advanced bronchogenic carcinoma, secondary liver metastasis, and sepsis. He presented for the first time in over a year since he started experiencing symptoms. He had no contact with his primary care physicians, nor was he vaccinated against the influenza virus or the coronavirus.

Learning Objectives

  • To review the subject of Bronchogenic Carcinoma (BC).
  • To address primary prevention as a huge player in reducing the burden of BC.
Keywords

chronic diseases; bronchogenic carcinoma; liver metastasis; sepsis

Cite This Article

Evbayekha O. E. MD., Izirein O. H. MD., Ohikhuai E. E. B. Pharm, MPH., Gabriel, A. MD., Okelue, E. O. MD MSC., Ovie, O. MD., Osaruyi, O. E. MD. (2022). Advanced Bronchogenic Carcinoma with Secondary Liver Metastasis and Sepsis as an Initial Hospital Presentation; The Shortcomings of Preventive Care Medicine in Nigeria. International Journal of Scientific Advances (IJSCIA), Volume 3| Issue 3: May-Jun 2022, Pages 463-466, URL: https://www.ijscia.com/wp-content/uploads/2022/06/Volume3-Issue3-May-Jun-No.285-463-466.pdf

Volume 3 | Issue 3: May-Jun 2022 

 

ISSN: 2708-7972

สัญญาอนุญาตของครีเอทีฟคอมมอนส์

This work is licensed under a Creative Commons Attribution 4.0 (International) Licence.(CC BY-NC 4.0).

Download

Support